Private Advisor Group, LLC
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1567755
MORRISTOWN, NJ
Position in ZNTL
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$73,644
New position
Shares Held
31,472
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $54,215,312 across 44 Biotechnology names. ZNTL ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,315 | $13,378,261 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,648,556 | $12,644,424 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
106,662 | $5,073,911 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,433 | $3,765,671 | |
| 5 | CRMD |
CorMedix Inc.
|
504,668 | $3,426,695 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
174,415 | $1,669,151 | |
| 7 | AVXL |
Anavex Life Sciences Corp.
|
499,700 | $1,534,079 | |
| 8 | CDXS |
Codexis, Inc.
|
847,001 | $1,380,611 |
All Filings in ZNTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $73,644 | 31,472 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||